Abstract:Ochratoxin A (OTA) is a nephrotoxic mycotoxin. There is evidence that OTA leads to cortical interstitial nephropathies in humans, associated with fibrosis. No data are available on the effect of OTA-induced collagen secretion from renal cortical cells. As kidney cortex mainly consists of proximal tubules, we investigated the effect of OTA on particular collagens (I, III, IV) in a well-established proximal tubular cell line (opossum kidney (OK) cells) and in primary cultured human renal proximal tubular epithel… Show more
“…We could show previously that OTA induces fibrosis in proximal tubular cells (Sauvant et al, 2004(Sauvant et al, , 2005. Thus, we investigated the effect of ERK1/2 inhibition on OTA-induced secretion of collagen I, III, and IV by specific ELISA technique (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, we recently investigated the effect of OTA on selected parameters of chronic renal cortical disease in proximal tubular cell lines (Sauvant et al, 2004(Sauvant et al, , 2005. In the mentioned studies, we could show that OTA induces loss of cell number, necrosis and apoptosis, fibrosis, inflammation, and epithelial to mesenchymal transition in proximal tubular cells.…”
Ochratoxin A (OTA) is a mycotoxin involved in the development of chronic nephropathies and a known carcinogen. As we have shown previously, OTA activates mitogen-activated protein kinases [extracellular signal-regulated kinase 1 and 2 (ERK1/2), c-jun amino-terminal kinase (JNK), and extracellular-regulated protein kinase 38 (p38)] in proximal tubular cells (opossum kidney and normal rat kidney epithelial). ERK1/2, JNK, or p38 are thought to mediate opposite action on apoptosis, fibrosis, and inflammation. As we have already shown, OTA activates the latter processes. Here, we investigated the effect of OTA in the absence or presence of the ERK1/2 inhibitor U0126 [1,4-diamino-2,3-dicyano-1,4bis(2-aminophenylthio)-butadiene] to test whether OTA then will exert increased toxicity. In the presence of ERK1/2 inhibition, OTA decreased cell number and protein to a significantly larger extent compared with OTA alone. The same was true for epithelial tightness, apoptosis (caspase-3 activity), and necrosis (lactate dehydrogenase release). Furthermore, simultaneous inhibition of ERK1/2 amplified the effect of OTA on markers of inflammation (nuclear factor of the -enhancer in B cells activity), fibrosis (collagen secretion), and epithelial mesenchymal transition (␣ smooth muscle actin). OTA induces phenomena typical for chronic interstitial nephropathy and activates ERK1/2, JNK, and p38 in proximal tubular cells. Inhibition of ERK1/2 aggravates the effects of OTA or even induces toxicity at normally nontoxic concentrations. This is highly likely due to activation of JNK and p38. Our data indicate a new mechanistic explanation for the toxic actions induced by OTA, and they are notable with respect to a possible coexposition of the kidney to OTA and naturally occurring ERK1/2 inhibitors. Finally, our data give rise to an attractive hypothesis on the coincidence of increased OTA exposition and urinary tract tumors in humans.
“…We could show previously that OTA induces fibrosis in proximal tubular cells (Sauvant et al, 2004(Sauvant et al, , 2005. Thus, we investigated the effect of ERK1/2 inhibition on OTA-induced secretion of collagen I, III, and IV by specific ELISA technique (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, we recently investigated the effect of OTA on selected parameters of chronic renal cortical disease in proximal tubular cell lines (Sauvant et al, 2004(Sauvant et al, , 2005. In the mentioned studies, we could show that OTA induces loss of cell number, necrosis and apoptosis, fibrosis, inflammation, and epithelial to mesenchymal transition in proximal tubular cells.…”
Ochratoxin A (OTA) is a mycotoxin involved in the development of chronic nephropathies and a known carcinogen. As we have shown previously, OTA activates mitogen-activated protein kinases [extracellular signal-regulated kinase 1 and 2 (ERK1/2), c-jun amino-terminal kinase (JNK), and extracellular-regulated protein kinase 38 (p38)] in proximal tubular cells (opossum kidney and normal rat kidney epithelial). ERK1/2, JNK, or p38 are thought to mediate opposite action on apoptosis, fibrosis, and inflammation. As we have already shown, OTA activates the latter processes. Here, we investigated the effect of OTA in the absence or presence of the ERK1/2 inhibitor U0126 [1,4-diamino-2,3-dicyano-1,4bis(2-aminophenylthio)-butadiene] to test whether OTA then will exert increased toxicity. In the presence of ERK1/2 inhibition, OTA decreased cell number and protein to a significantly larger extent compared with OTA alone. The same was true for epithelial tightness, apoptosis (caspase-3 activity), and necrosis (lactate dehydrogenase release). Furthermore, simultaneous inhibition of ERK1/2 amplified the effect of OTA on markers of inflammation (nuclear factor of the -enhancer in B cells activity), fibrosis (collagen secretion), and epithelial mesenchymal transition (␣ smooth muscle actin). OTA induces phenomena typical for chronic interstitial nephropathy and activates ERK1/2, JNK, and p38 in proximal tubular cells. Inhibition of ERK1/2 aggravates the effects of OTA or even induces toxicity at normally nontoxic concentrations. This is highly likely due to activation of JNK and p38. Our data indicate a new mechanistic explanation for the toxic actions induced by OTA, and they are notable with respect to a possible coexposition of the kidney to OTA and naturally occurring ERK1/2 inhibitors. Finally, our data give rise to an attractive hypothesis on the coincidence of increased OTA exposition and urinary tract tumors in humans.
“…Transdifferentiation has furthermore been discussed in relation to BEN (Markovic-Lipkovski, 2002). Indeed, Sauvant and colleagues hypothesized epithelialto-mesenchymal transition because of OTA-induced enhancement of collagen secrection in OK cells and primary human proximal tubular epithelial cells (RPTECs) (Sauvant et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…The latter findings, coupled with the observations that fibroblasts are less susceptible to ochratoxin-mediated toxicity (Grotegut et al, 2001;O'Brien et al, 2001), gave rise to the hypothesis that repeated exposure to ochratoxins alters normal renal epithelial cells, possibly converting them to a more fibroblast-like nature, thus, providing the rudiments for renal fibrosis (van Kooten et al, 2001). Support for this hypothesis was presented by the recent publication of Sauvant et al (2005), who described an increase in collagen synthesis in OK cells and primary human renal proximal tubular epithelial cells (RPTEC) following exposure to OTA. All of these observations are mostly descriptive in nature and need to be further characterized.…”
In the present study an in vitro model of subchronic repeated exposure to OTA and OTB was employed to generate ochratoxinderived subpopulations of human and porcine proximal tubular cells (HKC, IHKE, PKC, LLC-PK1). These cell subpopulations were subsequently used to investigate effects on cell proliferation rates, expression of marker proteins (cytokeratins, vimentin) and the acute cytotoxicity of OTA and OTB (MTT reduction, neutral red uptake, cell number). The hypothesis was tested whether repeated exposure at moderate concentrations of these toxins could provide for a reduced sensitivity of selected cell subpopulations to subsequent toxin exposure. Despite the observed increased cell population doubling times and the reduced sensitivity toward OTA and OTB exposure of some cell types, with the exception of the primary human epithelial cells, no overt changes in the expression of cytokeratin and vimentin could be determined. The presented data, however suggest that repeated exposure of renal epithelial cells to ochratoxins A or B will provide for a subpopulation of cells with reduced ochratoxin-sensitivity and alterations in growth characteristics.
“…OTA has been classified as a possible human carcinogen (Group 2B) by the International Agency for Research on Cancer (IARC, 1993). OTA has been shown to be a nephrotoxic (Sauvant et al, 2005), hepatotoxic (Ayed-Boussema et al, 2012), teratogenic (Wangikar et al, 2005) and immunotoxic (Mechoud et al, 2012) mycotoxin to several species of animals, and it has been reported to cause kidney and liver tumors in mice and rats (Huff, 1991). OTA can be metabolized in the kidney, liver and intestines (Wu et al, 2011).…”
Our previous study detected aflatoxins in red chili peppers from Chile, Bolivia, and Peru, each of which have a high incidence of gallbladder cancer (GBC). Since the aflatoxin B1 concentration was not so high in these peppers, it is important to clarify the presence of other mycotoxins. Here we attempted to determine any associations between the concentrations of aflatoxins and ochratoxin A (OTA) in red chili peppers, and the corresponding GBC incidences. We collected red chili peppers from three areas in Peru: Trujillo (a high GBC incidence area), Cusco (an intermediate GBC incidence area), and Lima (a low GBC incidence rate), and from Chile and Bolivia. Aflatoxins and OTA were extracted with organic solvents. The concentrations of aflatoxins B1, B2, G1, and G2, and OTA were measured by high-performance liquid chromatography. The values obtained were compared with the incidence of GBC in each area or country. All of the red chili peppers from the three areas showed contamination with aflatoxins below the Commission of the European Communities (EC) recommended limits (5 μg/kg), but the OTA contamination of two samples was above the EC recommended limit (15 μg/kg). The mean concentrations of OTA in the peppers from Chile (mean 355 μg/kg, range <5-1,059 μg/kg) and Bolivia (mean 207 μg/kg, range 0.8-628 μg/kg), which has a high incidence of GBC, were higher than that in Peru (14 μg/kg, range <5-47 μg/kg), which has an intermediate GBC incidence. The OTA contamination in the red chili peppers from Chile, Bolivia, and Peru was stronger than that of aflatoxins. Our data suggest that OTA in red chili peppers may be associated with the development of GBC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.